This site is intended for health professionals only!

Published on 12 March 2008

Share this story:
Twitter
LinkedIn

FDA warning over cough medication

teaser

The FDA has issued a warning about cough medication Tussionex Pennkinetic Extended-Release Suspension after receiving reports of side-effects, including death, in people taking it.

Tussionex is a prescription cough medicine containing hydrocodone and the antihistamine chlorpheniramine.

It is approved for use in adults and children over the age of six, and should not be taken more than once every 12 hours.

But doctors and other health professionals are sometimes prescribing more than the recommended dose, or patients are taking the medication more frequently than they should.

Reports also show that Tussionex is sometimes prescribed to children younger than six years old, and at least one of the patients later died.

Manufacturer UCB has agreed to update the labelling.

Copyright © PA Business 2008

FDA



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn